Literature DB >> 25539105

Transparency and the European Medicines Agency--sharing of clinical trial data.

Sergio Bonini1, Hans-Georg Eichler, Noël Wathion, Guido Rasi.   

Abstract

Mesh：

Year:  2014        PMID： 25539105     DOI： 10.1056/NEJMp1409464

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

1.  Be open about drug failures to speed up research.

Authors:  Enrica Alteri; Lorenzo Guizzaro
Journal:  Nature       Date:  2018-11       Impact factor: 49.962

Review 2.  Pharmaceutical Benefit-Risk Communication Tools: A Review of the Literature.

Authors:  Dominic Way; Hortense Blazsin; Ragnar Löfstedt; Frederic Bouder
Journal:  Drug Saf       Date:  2017-01       Impact factor: 5.606

Review 3.  Standards for design and measurement would make clinical research reproducible and usable.

Authors:  Kay Dickersin; Evan Mayo-Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-13       Impact factor: 11.205

4.  Availability and Use of Shared Data From Cardiometabolic Clinical Trials.

Authors:  Muthiah Vaduganathan; Amulya Nagarur; Arman Qamar; Ravi B Patel; Ann Marie Navar; Eric D Peterson; Deepak L Bhatt; Gregg C Fonarow; Clyde W Yancy; Javed Butler
Journal:  Circulation       Date:  2017-11-13       Impact factor: 29.690

Review 5.  The value of anticancer drugs - a regulatory view.

Authors:  Francesco Pignatti; Ulla Wilking; Douwe Postmus; Nils Wilking; Julio Delgado; Jonas Bergh
Journal:  Nat Rev Clin Oncol       Date:  2021-12-06       Impact factor: 66.675

Review 6.  Patient involvement in clinical research: why, when, and how.

Authors:  José A Sacristán; Alfonso Aguarón; Cristina Avendaño-Solá; Pilar Garrido; Juan Carrión; Alipio Gutiérrez; Robert Kroes; Angeles Flores
Journal:  Patient Prefer Adherence       Date:  2016-04-27       Impact factor: 2.711

7.  A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada.

Authors:  Steven G Morgan; Marc-André Gagnon; Barbara Mintzes; Joel Lexchin
Journal:  Healthc Policy       Date:  2016-08

8.  Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.

Authors:  Jennifer E Miller; Marc Wilenzick; Nolan Ritcey; Joseph S Ross; Michelle M Mello
Journal:  BMJ Open       Date:  2017-12-05       Impact factor: 2.692

9.  Restoring invisible and abandoned trials of gabapentin for neuropathic pain: a clinical and methodological investigation.

Authors:  Evan Mayo-Wilson; Xiwei Chen; Riaz Qureshi; Stephanie Dickinson; Lilian Golzarri-Arroyo; Hwanhee Hong; Carsten Görg; Tianjing Li
Journal:  BMJ Open       Date:  2021-06-30       Impact factor: 2.692

10.  Trends in global clinical trial registration: an analysis of numbers of registered clinical trials in different parts of the world from 2004 to 2013.

Authors:  Roderik F Viergever; Keyang Li
Journal:  BMJ Open       Date:  2015-09-25       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.